FDA Inspection 931958 — HP Halden Pharma AS

HP Halden Pharma AS — FEI 3002608066

The FDA completed an inspection of HP Halden Pharma AS on June 26, 2015 in Halden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 26, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Halden (Norway)